Loading…
AMBANI ORGOCHEM (AMBANIORGO)₹173.00−0.43%Specialty Chemicals
In the Sep 2026 quarter (consolidated), AMBANI ORGOCHEM reported sales of ₹170 Cr, up 53.9% from Sep 2025, and net profit of ₹3.01 Cr. For the year to Mar 2026, sales were ₹240 Cr and net profit ₹1.01 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 61.81 | 73.71 | 81.65 | 112 | 111 | 132 | 170 |
| Expenses | 57.97 | 73.99 | 77.01 | 106 | 103 | 125 | 160 |
| Operating Profit | 5.01 | 0.00 | 4.01 | 6.01 | 8.02 | 8.01 | 11.01 |
| OPM % | 8.0% | 0.5% | 5.0% | 6.0% | 7.0% | 6.0% | 7.0% |
| Other Income | 0.00 | 4.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Interest | 3.01 | 4.01 | 4.02 | 3.01 | 5.02 | 4.01 | 5.02 |
| Depreciation | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 2.01 | 2.01 |
| Profit before tax | 0.00 | 0.00 | −1.01 | 2.01 | 1.01 | 3.01 | 5.01 |
| Tax % | 62.9% | −5,960.1% | 32.9% | 46.9% | 86.9% | 56.9% | 24.9% |
| Exceptional items | 0.00 | 4.72 | 0.00 | 0.48 | 0.00 | 0.00 | 0.67 |
| Net Profit | 0.00 | 3.01 | −2.01 | 1.01 | 0.00 | 1.01 | 3.01 |
| EPS (Rs) | 0.15 | 4.14 | −2.51 | 1.20 | 0.24 | 1.48 | 3.97 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.77 | 64.81 | 78.71 | 72.77 | 86.66 | 125 | 131 | 135 | 192 | 240 |
| Expenses | 49.02 | 59.99 | 74.01 | 67.99 | 80.95 | 118 | 124 | 131 | 183 | 227 |
| Operating Profit | 3.01 | 5.01 | 6.01 | 5.01 | 6.01 | 6.02 | 8.02 | 5.01 | 9.01 | 14.03 |
| OPM % | 6.0% | 7.0% | 7.0% | 7.0% | 7.0% | 5.0% | 6.0% | 3.5% | 4.9% | 6.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 4.99 | 1.99 | 2.99 |
| Interest | 2.01 | 2.01 | 3.01 | 3.01 | 3.01 | 3.01 | 4.01 | 7.02 | 8.03 | 9.03 |
| Depreciation | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 3.01 | 3.01 | 4.01 |
| Profit before tax | 1.01 | 2.01 | 2.01 | 2.01 | 3.01 | 3.01 | 3.01 | 0.00 | 0.00 | 4.01 |
| Tax % | 32.0% | 16.9% | 27.9% | 39.0% | 34.9% | 27.9% | 34.9% | −1,116.1% | 299.9% | 67.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.99 | 0.00 | 0.00 |
| Net Profit | 1.01 | 2.01 | 2.01 | 1.01 | 2.01 | 2.01 | 2.01 | 3.01 | −1.01 | 1.01 |
| EPS (Rs) | 2.09 | 4.62 | 3.40 | 2.71 | 3.34 | 3.11 | 3.07 | 4.30 | −1.10 | 1.73 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.99 | 3.99 | 4.98 | 4.99 | 4.98 | 5.98 | 5.98 | 6.97 | 7.98 | 7.98 |
| Reserves | 0.00 | 2.00 | 9.98 | 12.00 | 12.99 | 23.97 | 25.98 | 38.93 | 44.00 | 43.99 |
| Borrowings | 13.02 | 15.97 | 14.97 | 20.00 | 33.98 | 52.94 | 71.92 | 60.88 | 60.03 | 76.01 |
| Other Liabilities | 21.89 | 25.87 | 30.85 | 25.87 | 24.88 | 28.86 | 32.85 | 67.67 | 96.53 | 95.54 |
| Total Liabilities | 37.90 | 47.83 | 60.78 | 61.86 | 77.83 | 112 | 137 | 175 | 208 | 223 |
| Fixed Assets | 11.98 | 12.98 | 12.98 | 14.99 | 20.99 | 21.99 | 20.99 | 58.90 | 76.88 | 77.99 |
| CWIP | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 | 8.99 | 47.04 | 8.01 | 7.01 | 11.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 25.92 | 34.85 | 47.80 | 45.86 | 55.84 | 79.77 | 68.70 | 109 | 124 | 134 |
| Inventories | 5.99 | 9.98 | 16.96 | 16.97 | 17.95 | 20.95 | 22.97 | 28.93 | 40.94 | 41.92 |
| Trade receivables | 15.99 | 18.01 | 23.01 | 22.99 | 29.99 | 32.02 | 27.99 | 26.98 | 42.01 | 49.99 |
| Cash & equivalents | 1.01 | 0.99 | 3.01 | 3.01 | 3.01 | 10.99 | 5.99 | 7.01 | 16.01 | 16.01 |
| Total Assets | 37.90 | 47.83 | 60.78 | 61.86 | 77.83 | 112 | 137 | 175 | 208 | 223 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.01 | 3.01 | −2.01 | 5.01 | −4.01 | 0.00 | 17.03 | −12.02 | 12.04 | 0.00 |
| Cash from investing activity | −2.01 | −2.01 | −0.99 | −4.01 | −6.01 | −20.01 | −38.02 | −0.99 | 2.01 | −8.01 |
| Cash from financing activity | −2.01 | −1.01 | 5.01 | −2.01 | 10.02 | 27.04 | 16.02 | 14.02 | −3.01 | 8.01 |
| Net cash flow | 0.00 | 0.00 | 2.99 | −0.99 | 0.99 | 6.98 | −4.98 | 0.99 | 9.96 | −0.99 |
| Capex | 2.02 | 1.99 | 1.33 | 3.62 | 5.91 | 12.06 | 38.51 | 17.58 | 20.06 | 9.00 |
| Free cash flow | 1.99 | 0.99 | −2.99 | 0.99 | −9.98 | −11.98 | −20.95 | −12.98 | −8.99 | −8.98 |
| CFO / OP % | 123.0% | 80.1% | −19.0% | 96.1% | −57.0% | 6.0% | 223.0% | −262.0% | 124.1% | 1.0% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 112 | 103 | 104 | 117 | 127 | 94 | 78 | 72 | 80 | 76 |
| Inventory days | 53 | 70 | 95 | 102 | 92 | 75 | 77 | 100 | 103 | 89 |
| Days payable | 130 | 132 | 135 | 101 | 82 | 64 | 73 | 195 | 214 | 177 |
| Cash conversion cycle | 36 | 43 | 66 | 119 | 139 | 106 | 84 | −21 | −28 | −10 |
| Working capital days | −9 | 2 | 30 | 41 | 35 | 16 | −15 | 17 | −30 | −22 |
| ROCE % | — | 22.1% | 20.0% | 15.1% | 12.1% | 9.1% | 8.1% | 2.0% | 7.1% | 11.1% |
For the Sep 2026 quarter, AMBANI ORGOCHEM reported sales of ₹170 Cr, up 53.9% year on year and net profit of ₹3.01 Cr. The operating margin was 7.0%.
AMBANI ORGOCHEM's sales for the year to Mar 2026 were ₹240 Cr.
Net profit for the year to Mar 2026 was ₹1.01 Cr. Earnings per share over the same trailing period were ₹1.73.
AMBANI ORGOCHEM reported borrowings of ₹76.01 Cr at Mar 2026, against cash and equivalents of ₹16.01 Cr.
Cash from operations was ₹0 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.98 Cr.